Cytochrome p450 2C inhibition reduces post-ischemic vascular dysfunction (Q46693356)

24 December 2017

title

Cytochrome p450 2C inhibition reduces post-ischemic vascular dysfunction (English)

1 reference

24 December 2017

1 reference

24 December 2017

author name string

Arwen L Hunter

series ordinal

1 reference

24 December 2017

Ni Bai

series ordinal

1 reference

24 December 2017

David J Granville

series ordinal

1 reference

24 December 2017

publication date

8 September 2005

1 reference

24 December 2017

published in

Vascular Pharmacology

1 reference

24 December 2017

volume

1 reference

24 December 2017

issue

1 reference

24 December 2017

page(s)

213-219

1 reference

24 December 2017

Cytochrome p-450 epoxygenase products contribute to attenuated vasoconstriction after chronic hypoxia

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2005.07.005

Inhibition of cytochrome P450 2C9 improves endothelium-dependent, nitric oxide-mediated vasodilatation in patients with coronary artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2005.07.005

Cytochrome P450 epoxygenases and vascular tone: novel role for HMG-CoA reductase inhibitors in the regulation of CYP 2C expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2005.07.005

Endothelium-derived hyperpolarizing factor synthase (Cytochrome P450 2C9) is a functionally significant source of reactive oxygen species in coronary arteries.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2005.07.005

Reduction of ischemia and reperfusion-induced myocardial damage by cytochrome P450 inhibitors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2005.07.005

Cytochrome p450 enzymes and cardiovascular disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2005.07.005

Selectivities of human cytochrome P450 inhibitors toward rat P450 isoforms: study with cDNA-expressed systems of the rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2005.07.005

Plasma phospholipase A2 activity in clinical acute myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2005.07.005

Endothelial and myogenic regulation of coronary artery tone in the mouse

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2005.07.005

Substrate selectivity of human cytochrome P450 2C9: importance of residues 476, 365, and 114 in recognition of diclofenac and sulfaphenazole and in mechanism-based inactivation by tienilic acid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2005.07.005

Attenuation of ischemia and reperfusion injury of canine livers by inhibition of type II phospholipase A2 with LY329722.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2005.07.005

Myocardial and coronary endothelial protective effects of acetylcholine after myocardial ischaemia and reperfusion in rats: role of nitric oxide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2005.07.005

Enhanced postischemic functional recovery in CYP2J2 transgenic hearts involves mitochondrial ATP-sensitive K+ channels and p42/p44 MAPK pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2005.07.005

Profound inhibition of myogenic tone in rat cardiac allografts is due to eNOS- and iNOS-based nitric oxide and an intrinsic defect in vascular smooth muscle contraction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2005.07.005

The effect of chronic treatment with trandolapril on cyclic AMP-and cyclic GMP-dependent relaxations in aortic segments of rats with chronic heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2005.07.005

Accumulation of arachidonic acid in ischemic/reperfused cardiac tissue: possible causes and consequences

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2005.07.005

Effect of CYP1A1 MspI polymorphism on cigarette smoking related coronary artery disease and diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2005.07.005

Gender differences in coronary artery diameter involve estrogen, nitric oxide, and Ca(2+)-dependent K+ channels

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2005.07.005

Inhibition of mitochondrial calcium-independent phospholipase A2 (iPLA2) attenuates mitochondrial phospholipid loss and is cardioprotective

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2005.07.005

Molecular cloning, expression, and functional significance of a cytochrome P450 highly expressed in rat heart myocytes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2005.07.005

Allelic variants of cytochromes P450 2C modify the risk for acute myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2005.07.005

Superoxide production in vascular smooth muscle contributes to oxidative stress and impaired relaxation in atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2005.07.005

inferred from DOI database lookup

7 January 2021

based on heuristic

Induction of cardiac cytochrome p450 in cocaine-treated mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2005.07.005

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.VPH.2005.07.005

1 reference

24 December 2017

1 reference

24 December 2017